Catalyst Pharmaceuticals (CPRX) Capital Expenditures (2011 - 2026)
Catalyst Pharmaceuticals (CPRX) posted Capital Expenditures of $27,000 for Q1 2026, down 15.6% from the prior quarter.
Powered by 
Analysis
Catalyst Pharmaceuticals (CPRX) Capital Expenditures (2011 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, Capital Expenditures at Catalyst Pharmaceuticals was $85,000, down 76.2% year-over-year; for FY2025, it came in at $58,000, down 89.6% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of 39.4% (FY2020 to FY2025).
- In prior years, Catalyst Pharmaceuticals' Capital Expenditures was $556,000 in FY2024 (+140.7%), $231,000 in FY2023 (+696.6%), $29,000 in FY2022 (-97.2%) and $1.02 million in FY2021.
- Quarterly Capital Expenditures has run from a low of $1,000 in Q2 2021 to a high of $259,000 in Q3 2024 over five years.
- On a year-over-year basis, Capital Expenditures increased in two of the last four quarters, with growth averaging 98.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 1.04 Bn | 134.92 Mn | 27,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 27,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Dec 31, 2024 | 88,000.00 |
| Sep 30, 2024 | 259,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 199,000.00 |
| Dec 31, 2023 | 93,000.00 |
| Sep 30, 2023 | 64,000.00 |
| Mar 31, 2023 | 74,000.00 |
| Dec 31, 2021 | 41,000.00 |
| Sep 30, 2021 | 68,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 911,000.00 |
| Dec 31, 2019 | -370.00 |
| Jun 30, 2019 | 13,737.00 |
| Mar 31, 2019 | 5,633.00 |
| Dec 31, 2018 | 56,825.00 |
| Sep 30, 2018 | 23,256.00 |
| Jun 30, 2018 | 11,937.00 |
API Access
Catalyst Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();